Moreover, miR-124-3p and miR-451 are other anti-oncogenic miRNAs that sensitize breast cancer cells to doxorubicin by targeting P-gp (Kovalchuk et al., 2008; Hu et al., 2019). The gene discussed is PGP; the disease is breast cancer.